Table 4 Evolution of procalcitonin levels in the last week of hospitalization for survivor and non-survivor groups
| Last week of hospitalization | ||||||
|---|---|---|---|---|---|---|
| Survivors | Non-survivors | |||||
| Day | N | Median | Q1–Q3 | N | Median | Q1–Q3 |
| 1 | 67 | 0.180 | 0.100–0.395 | 22 | 1.050 | 0.700–2.370 |
| 2 | 68 | 0.160 | 0.095–0.435 | 24 | 1.0150 | 0.435–2.830 |
| 3 | 68 | 0.150 | 0.080–0.400 | 26 | 1.1100 | 0.560–2.510 |
| 4 | 68 | 0.160 | 0.080–0.320 | 26 | 1.2000 | 0.460–2.825 |
| 5 | 68 | 0.150 | 0.070–0.355 | 27 | 1.4700 | 0.650–3.570 |
| 6 | 68 | 0.140 | 0.070–0.360 | 28 | 2.3650 | 0.710–5.820 |
| 7 | 68 | 0.125 | 0.070–0.365 | 31 | 3.8200 | 1.100–10.235 |